NCT00166400View on ClinicalTrials.gov

A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.

PHASE4CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Heart Valve Diseases

Interventions

DRUG

metoprolol succinate

Treatment with potent beta-blockade titrated to the maximally tolerated dose.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Mayo Clinic

OTHER